Evidence map›Paper›PMID 33044859›Full record

ArticleCirculation2020

Response by Kazi et al to Letter Regarding Article, "Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy".

Dhruv S Kazi, Brandon K Bellows, John A Spertus, Suzanne J Baron, Changyu Shen, David J Cohen, Robert W Yeh, Suzanne V Arnold, Brett W Sperry, Mathew S Maurer and 1 more

Open access · bronzeAbstract readLetterComment
In one paragraph

Article in Circulation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Dhruv S KaziRichard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Boston, MA (D.S.K., S.J.B., C.S., R.W.Y.).
Brandon K BellowsColumbia University Irving Medical Center, New York, NY(B.K.B., M.S.M.).
John A SpertusSaint Luke's Mid America Heart Institute, Kansas City, MO(J.A.S.).
Suzanne J BaronRichard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Boston, MA (D.S.K., S.J.B., C.S., R.W.Y.).
Changyu ShenRichard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Boston, MA (D.S.K., S.J.B., C.S., R.W.Y.).
David J CohenUniversity of Missouri-Kansas City(J.A.S., D.J.C., S.V.A., B.W.S.).
Robert W YehRichard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Boston, MA (D.S.K., S.J.B., C.S., R.W.Y.).
Suzanne V ArnoldUniversity of Missouri-Kansas City(J.A.S., D.J.C., S.V.A., B.W.S.).
Brett W SperryUniversity of Missouri-Kansas City(J.A.S., D.J.C., S.V.A., B.W.S.).
Mathew S MaurerColumbia University Irving Medical Center, New York, NY(B.K.B., M.S.M.).
Sanjiv J ShahNorthwestern University Feinberg School of Medicine, Chicago, IL (S.J.S.).
Lahey Hospital and Medical Center · USMount Sinai Beth Israel · USColumbia University Irving Medical Center · USNorthwestern University · USSaint Luke's Hospital · USUniversity of Missouri–Kansas City · US

Funding

SCAN-MP (Screening for Cardiac Amyloidosis with Nuclear imaging in Minority Populations) COVID-19 SuppplementR01HL139671 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MAURER, MATHEW S, RUBERG, FREDERICK LIEF · 2019 to 2023
$7.4M
Transition from Risk Factors to Early HF: Prevalence, Pathogenesis, and PhenomicsR01HL127028 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI BERTONI, ALAIN GERALD, SHAH, SANJIV J · 2015 to 2018
$6.5M
Study of Cardiac Mechanics in Systemic HypertensionR01HL107577 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SHAH, SANJIV J · 2011 to 2019
$4.1M
Machine learning for the automated identification and tracking of rare myocardial diseasesR01HL140731 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MACRAE, CALUM A., SHAH, SANJIV J · 2018 to 2021
$2.8M
Precision Medicine for Dilated Cardiomyopathy—Novel Assessment of Cardiac Mechanics via Speckle Tracking Echocardiography to Identify Early PhenotypesR01HL149423 · NHLBI · OHIO STATE UNIVERSITY · PI HERSHBERGER, RAY E., KINNAMON, DANIEL DAVIS · 2019 to 2022
$1.6M
Midcareer Mentoring Award for Patient Oriented Research in Geriatric CardiologyK24AG036778 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MAURER, MATHEW S · 2010 to 2020
$1.6M
Comparing the value of intensive systolic blood pressure treatment implementation strategiesK01HL140170 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BELLOWS, BRANDON K · 2018 to 2022
$709k
Analysis of Lumbar Spine Stenosis Speciments for Early Identification of TTR Cardiac AmyloidosisR21AG058348 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MAURER, MATHEW S · 2018 to 2019
$456k
NHLBI NIH HHS K01 HL140170NHLBI NIH HHS R01 HL107577NHLBI NIH HHS R01 HL127028NHLBI NIH HHS R01 HL139671NHLBI NIH HHS R01 HL140731NHLBI NIH HHS R01 HL149423NIA NIH HHS K24 AG036778NIA NIH HHS R21 AG058348
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Amyloid Neuropathies, FamilialCardiomyopathiesBenzoxazolesCost-Benefit AnalysisHumansPrealbuminBenzoxazolesPrealbumintafamidis

Identifiers

PMID33044859
PMCPMC8170666
OpenAlexW3091823603

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.